Cardiology transaction activity remains strong, but the underlying investment strategy has evolved significantly over the last several years. Historically, many cardiovascular procedures were confined to the hospital setting because Medicare reimbursement and regulatory limitations restricted migration to outpatient settings. Today, that dynamic is changing rapidly. Expanded reimbursement eligibility, advancements in procedural technology, and growing confidence in ambulatory cardiovascular care are reshaping how investors, health systems, and physician groups approach cardiology outpatient strategy.
Read the full article: Scaling Cardiology: How Site-of-Care Strategy Is Reshaping M&A //
Source: https://vmghealth.com/insights/blog/scaling-cardiology-how-site-of-care-strategy-is-reshaping-ma/
